The share price is hovering the lowest it's been since listing 7 years ago & regardless of what we've been complaining, concerned, frustrated about looking back i think it's pretty clear that at all time lows in value & market price the company itself has never been in a better position.
Roche/Pfizer/Astrazeneca/Johnson&Johnson on the books
milestones of atleast $400M with potential to expand to $2B
so the deals with 4 of the worlds largest pharmaceutical companies over the past 3 years in retrospect has devalued the company ?
I just find it kind of ironic in Sunday thought :-)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.42 |
Change
0.030(2.16%) |
Mkt cap ! $828.2M | |||
| Open | High | Low | Value | Volume |
| $1.39 | $1.42 | $1.35 | $262.9K | 189.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 7220 | $1.39 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.42 | 31411 | 3 |
View Market Depth
| Last trade - 16.10pm 22/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |